Partnering with Indigenous Communities to Prevent Youth Vaping in the Southwest
Leveraging Community-Engaged Research to Co-Create Youth Vaping Prevention with Urban Indigenous Communities of the Southwest
This project works with urban Indigenous communities in the Southwest to create new ways to help prevent young people from starting to vape nicotine and cannabis.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Arizona State University-Tempe Campus NIH-funded |
| Lab location | 1 site (Scottsdale, United States) |
| Project ID | NIH-11172434 on NIH RePORTER |
What this research studies
We know that vaping is a big concern for Indigenous youth, especially in cities, where many young people live. This project aims to understand why vaping is so common and how it connects with other challenges these youth face, like navigating their ethnic identity. We will work directly with community members to develop prevention programs that truly fit their needs and experiences. Our goal is to create effective strategies that address the unique reasons why young people might start vaping, including misinformation and easy access to products.
Who could benefit from this research
Good fit: This project is for urban Indigenous youth and community members in the Southwest who are interested in preventing vaping.
Not a fit: Patients not residing in urban Indigenous communities of the Southwest or those not interested in vaping prevention may not directly benefit from this specific project.
Why it matters
Potential benefit: If successful, this work could lead to new, culturally relevant programs that significantly reduce vaping rates among urban Indigenous youth, improving their long-term health.
How similar studies have performed: While interventions for alcohol and other drugs have shown success, evidence-based interventions specifically for urban Indigenous youth vaping are currently lacking, making this a novel approach.
Where this research is happening
Scottsdale, United States
- Arizona State University-Tempe Campus — Scottsdale, United States (Active)
Researchers
- Principal investigator: Vollrath, Stephanie Ayers — Arizona State University-Tempe Campus
- Study coordinator: Vollrath, Stephanie Ayers
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.